It is also reported that IL-33 treatment suppressed pro-inflammatory cytokines production and improved the survival rate in sepsis mice by suppressing the IL-17 pathway through activating the suppressor of cytokine signaling (SOCS)-3 [34]. Here, IL33 is linked to Sepsis.